|
|
|
|
|
by refurb
1260 days ago
|
|
I worked in the biotech space and this - NCCN (US) or ESMO (EU) guidelines are the place to start. Unless you're a very unique case, most doctors won't even consider cutting edge therapies until you've failed at least one of the more common treatments. Sign up for a free account and download the guidelines. They are evidence driven and give you a sense of what the current standard of treatment is and how strong the evidence is. Not sure about ESMO, but NCCN even publishes a patient-friendly version now. If guidelines treatments fail (which would likely take a while as there are multiple lines of therapy) then you're getting into the clinical trial space and you'd likely need to get input from someone in academics who is close to the space and does research. But major hospitals usually have "tumor boards" where the oncologists get together and go through challenging patient cases and make recommendations on next steps. But sounds like OP is nowhere close to that. |
|